#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary adrenal insufficiency Vascular calcification Burkitt's lymphoma refractory Epstein-Barr virus associated lymphoproliferative disorder Prostate cancer Diabetes insipidus Retinal dystrophy Soft tissue necrosis Pyruvate kinase deficiency anaemia Cholangiosarcoma Mucopolysaccharidosis II Dermatitis Neurodegenerative disorder Marginal zone lymphoma recurrent Glomerulonephritis membranous More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Trials in Disease Pulmonary sarcoidosis – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Angelman’s syndrome Langerhans’ cell histiocytosis Idiopathic pulmonary fibrosis – Trials in Disease Toxic epidermal necrolysis Haemophilia B without inhibitors – Treatment Pemphigus – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Procarbazine Hydrochloride Vidofludimus Calcium Sertraline Ucp2 Quercus Robur Pollen Extract Sphingomyelin (Egg) Anb032 Lysine Hydrochloride TEV-53408 Betula Pollen Extract SECRETIN SYNTHETIC HUMAN Somapacitan Mianserin Hydrochloride Sorafenib Tosilate Astegolimab GVV858 Baloxavir Marboxil A/(H3N2)-LIKE VIRUS ANTIGEN (-)-PHENSERINE TARTRATE Elranatamab More therapies…

    Learn about Your Condition

    Invasive breast carcinoma Febrile neutropenia Syphilis Mastocytosis Vaginal haemorrhage Von Hippel-Lindau disease Adenocarcinoma Alveolar proteinosis Rheumatoid arthritis Wiskott-Aldrich syndrome Brain neoplasm malignant Laryngeal cancer stage III Decreased appetite Pyoderma Haemorrhagic stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Breslauer Strasse 201, Langwasser, Nürnberg, 90471, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Fluorouracil
    • Oxaliplatin
    Austria Germany

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Voclosporin
    • Rapcabtagene Autoleucel
    • Tacrolimus
    Austria Czechia Denmark France Germany Hungary +7

  • Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    Austria Belgium Czechia Denmark France Germany +5

  • Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Tacrolimus
    • Mycophenolic Acid
    Austria Belgium Czechia Finland France Germany +7

  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Austria Czechia Germany Greece Hungary Latvia +3

  • Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage IV
    • Malignant melanoma stage III
    Investigated Drugs:
    • Enomimeran
    • Gindameran
    • Ontasameran
    Germany Italy Poland Spain

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zolbetuximab
    • Capecitabine
    • Fluorouracil
    Belgium Czechia France Germany Italy Lithuania +5

  • Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Calcium Folinate Pentahydrate
    • Docetaxel
    Germany

  • Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    Germany
Previous Page
1 … 4 5 6 7 8 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!